Surgery Partners, Inc.

SGRY Healthcare Medical Care Facilities

Surgery Partners, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.3 billion, up 6.24% from fiscal 2024.

Revenue
+2.75%
EPS
−500.0%
Free cash flow
−60.6%
Total debt
+4.92%

Quarter to June 2026, against a year earlier

23.20 0.03 +0.13%
Market cap
$3.0B
P/E
0.0×
Fwd P/E
−35.3×
Dividend yield
—
F-score
4/9
Altman Z
0.75
Beneish M
−2.52
Dividend safety
4/100

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Revenue
1,145.44 1,341.20 1,771.50 1,831.40 1,860.10 2,225.10 2,539.30 2,743.30 3,114.30 3,308.70
Revenue Growth
19.33% 17.09% 32.08% 3.38% 1.57% 19.62% 14.12% 8.03% 13.52% 6.24%
Gross Profit
324.24 327.40 410.10 423.80 379.80 491.40 574.90 647.50 745.60 765.00
Operating Income
196.48 158.30 77.80 235.90 183.00 302.20 345.20 328.00 348.80 389.50
EBT
92.18 82.30 (69.20) 54.60 (18.80) 81.20 110.30 135.00 147.10 116.90
Income after Tax
85.08 28.70 (95.60) 45.10 1.30 70.70 87.00 135.30 12.50 98.90
Net Income Common
9.45 (79.10) (238.10) (110.50) (155.60) (81.20) (54.60) (11.90) (168.10) (77.90)
EPS (Diluted)
0.20 (1.64) (4.96) (2.27) (3.19) (1.12) (0.59) (0.09) (1.33) (0.61)
Shares (Diluted, Weighted)
48.19 48.32 48.03 48.28 48.78 72.43 91.95 125.61 126.12 127.21
Gross Margin
28.31% 24.41% 23.15% 23.14% 20.42% 22.08% 22.64% 23.60% 23.94% 23.12%
EBIT Margin
17.57% 12.28% 4.89% 13.44% 10.42% 14.09% 14.09% 12.47% 11.83% 12.46%
Net Profit Margin
0.83% (5.90%) (13.44%) (6.03%) (8.37%) (3.65%) (2.15%) (0.43%) (5.40%) (2.35%)
Free Cash Flow Margin
7.52% 6.81% 7.00% 4.01% 14.11% 1.60% 3.59% 8.41% 6.82% 7.32%
EBITDA
240.80 216.60 154.10 322.60 288.60 412.30 472.50 460.30 520.90 588.40
EBIT
201.25 164.70 86.70 246.10 193.80 313.50 357.70 342.20 368.30 412.40

Show all line items

In millions of $ except per-share values · columns are period end dates